Cardinal Health Annouces New Chinese Name ‘Jia De Nuo’

-Name Change Marks New Chapter in Commitment to China

BEIJING, March 30, 2019 /PRNewswire/ — Cardinal Health (NYSE: CAH) today unveiled its new Chinese name – Jia De Nuo at gathering of China’s leading cardiologists in Beijing. In Chinese, “Jia” means auspicious and happy, “De” represents ethics, and “Nuo” is promise, which reflects Cardinal Health’s deep commitment to meeting the needs of healthcare providers and patients in China.

Speaking at the name unveiling ceremony, Jessie Lian, General Manager of Cardinal Health China, said “Cardinal Health is a global leader in medical products with almost 100 years of experience and expertise in delivering high quality, clinically proven solutions that improve the lives of patients. We are committed to fostering strong local partnerships that will allow us to provide tailored products and solutions to the physicians, nurses and patients we serve in China.”

Left to right: Jessie Lian, Professor Junbo Ge, Professor Shubin Qiao, Professor Shaoping Nie
Left to right: Jessie Lian, Professor Junbo Ge, Professor Shubin Qiao, Professor Shaoping Nie

Ms Lian along with the country’s top cardiologists – Professor Junbo Ge, Academician of the Chinese Academy of Sciences, Director of Cardiology Department of Zhongshan Hospital, Professor Shubin Qiao, Chief Physician of Coronary Heart Disease Center of Fuwai Hospital, and Professor Shaoping Nie, Head of Emergency and Critical Care Center of Beijing Anzhen Hospital, jointly unveiled the new name, Jia De Nuo, at the launch event.

Over the last few years, Cardinal Health has taken strategic steps to expand its business footprint in China. Continued investment in Cardinal Health’s Cordis business has positioned the company for growth, offering trusted innovation in the cardiovascular space to enhance local patient care. Following the divestiture of its China distribution business in 2018, Cardinal Health China completed the integration of the Patient Recovery business from Medtronic in 2019, diversifying and increasing the depth of its medical products portfolio. These moves have enhanced Cardinal Health’s ability to supply China’s healthcare providers with a portfolio of high-quality products and solutions that span the entire continuum of care.

Professor Shaoping Nie stated, “Modern healthcare model is constantly transforming. It is an evoloving process that companies, healthcare providers and us physicians need to continuously embrace. What is not changing are the shared values and promises we made to the patients. With the new chapter of Cardinal Health China, through the shared promises, I look forward to working more closely together in our shared combat towards a healthier future for our patients.”

This year also marks the 60th anniversary of the establishment of Cordis. Professor Shubin Qiao commented, “Being one of the pioneers in the development of interventional vascular products and technology, Cordis has played a critical role in delivering leading products to treat many patients as well as in providing clinical trainings to many physicians in China.”

“1 in 5 adults has cardiovascular disease in China and the prevalence rate is still rising at a rapid pace. It is a major public health issue that can only be better managed through collaborations amongst all parties.” Professor Junbo Ge stated, “We have made great progress in the past years and we appreciate partners, such as Cardinal Health, to continuously support the development of cardiology in China.”

About Cardinal Health 

Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products, pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. To help combat prescription drug abuse, the company and its education partners created Generation Rx, a national drug education and awareness program. Backed by nearly 100 years of experience, with approximately 50,000 employees in nearly 46 countries, Cardinal Health ranks #14 on the Fortune 500. For more information, visit, follow @CardinalHealth on Twitter, @cardinalhealthwings on Facebook and connect on LinkedIn at company/cardinal-health.

About Cordis

Cordis, a Cardinal Health company, is a worldwide leader in the development and manufacture of interventional vascular technology. As of 2015, Cordis is a part of Cardinal Health, bringing together two important players in the healthcare industry and creating an unmatched combined offering in the cardiovascular space that will ensure greater access to quality products and services worldwide. Cordis is committed to equipping physicians with products that truly addresses clinical needs so that they can bring better outcomes for the patients. For the past 20 years in China, Cordis has been a trusted partner for healthcare professionals in the field of vascular intervention in China, and is committed to continue contributing for the future transformation and development of the industry.

Photo –

Related Post